Preserved T cell responses to SARS-CoV-2 in anti-CD20 treated multiple sclerosis.
Mult Scler
; 28(7): 1041-1050, 2022 06.
Article
in En
| MEDLINE
| ID: mdl-35575234
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19
/
Multiple Sclerosis
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Mult Scler
Journal subject:
NEUROLOGIA
Year:
2022
Type:
Article
Affiliation country:
Germany